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Regulation of gene expression requires selective incorporation of histone H3 variant H3.3 into
chromatin. Histone H3.3 has several subsidiary variants but their functions are unclear. Here
we characterize the function of histone H3.3 sub-variant, H3mm7, which is expressed in
skeletal muscle satellite cells. H3mm7 knockout mice demonstrate an essential role of
H3mm7 in skeletal muscle regeneration. Chromatin analysis reveals that H3mm7 facilitates
transcription by forming an open chromatin structure around promoter regions including
those of myogenic genes. The crystal structure of the nucleosome containing H3mm7 reveals
that, unlike the S57 residue of other H3 proteins, the H3mm7-specific A57 residue cannot
form a hydrogen bond with the R40 residue of the cognate H4 molecule. Consequently, the
H3mm7 nucleosome is unstable in vitro and exhibited higher mobility in vivo compared with
the H3.3 nucleosome. We conclude that the unstable H3mm7 nucleosome may be required
for proper skeletal muscle differentiation.
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Chromatin, composed of genomic DNA and histoneoctamers, dynamically changes its structure to achievecorrect gene regulation, replication, and repair of genomic
DNA. Thus far, chromatin structures have been characterized by
analysis of nucleosomes. Change in nucleosome positioning is
required for RNA polymerase II recruitment onto transcription
start sites (TSSs). The recent advances in understanding
chromatin structure have unveiled the diversity of histone
proteins, the so-called histone variants, which play specific roles
in specialized local chromatin structures1. However, the functions
of each histone variant are still unclear because the histone
variants are diverse.
Many histone H3 variants have been studied in the past
decade. CenH3/CENP-A has been characterized by its function
in the centromere to promote kinetochore functions2,3. It is
overexpressed in cancer cells and mislocalized to chromosome
arms forming heterotypic nucleosomes with the histone
variant H3.34. The diversified function of H3.3 has also
been studied in active transcribed gene loci during cell differ-
entiation or development, as well as in the centromere5. For
example, H3.3 knockout (KO) results in embryonic lethality
in mice6, and maternal H3.3 is required for the expression
of pluripotency genes in oocyte reprogramming7. Myogenesis is
a well-characterized model to understand H3.3 function in
gene regulation upon skeletal muscle differentiation. H3.3
is incorporated into skeletal muscle gene promoters prior to
differentiation8,9. The selective incorporation of H3.3 is antag-
onized by the ectopic expression of canonical histone H3.1, which
results in deficient skeletal muscle differentiation10. The repla-
cement of canonical histones by variants is considered to have a
general and important role in lineage specification5.
The distinct function of histone H3 variants has also been
demonstrated by their involvement in oncogenesis. Mutations in
canonical histone H3.1 are involved in diffuse intrinsic pontine
gliomas, while mutation of H3.3 promotes glioblastoma11 and is
reported in chondroblastoma and giant cell tumors12,13. These
reports indicate that the selective function of histone H3 variants
is required for gene expression as well as development.
We recently identified 14 novel mouse histone H3 variants
termed H3mm6-18 and H3t, some of which showed tissue-
specific expression14. Thirteen of these variants share functional
amino acid motifs with H3.3 and are suggested to be subsidiary
variants (sub-variants) of H3.3. We also identified an H3.1 sub-
variant, H3t; the H3t mRNA contains a stem-loop RNA structure
after the coding region15 indicating that it is a replication-coupled
histone. Deletion of the testis-specific H3t gene causes male
sterility16. The H3mm6–18 genes are predicted to be replication-
independent histone variants, because they have polyadenylation
signal sequences and are located outside the histone clusters.
However, the unique function of each H3.3-type variant remains
unclear. The ectopic expression of H3mm7 and H3mm11
resulted in specific expression profiles in skeletal muscle tissues
that were regulated during the differentiation of C2C12 mouse
myoblast cells. We therefore hypothesized that these histone
variants regulate gene expression during lineage commitment by
forming a special chromatin structure.
Here we demonstrate that the histone variant H3mm7 is
required for skeletal muscle differentiation. H3mm7 is expressed
in early stage muscle stem cells, and deletion of the H3mm7 gene
leads to deficient muscle cell regeneration and differentiation.
Transcriptome analysis of H3mm7−/− cells reveals rate changes
in the expression levels of skeletal-muscle-related genes.
Structural and biochemical analyses indicates that H3mm7
incorporation renders the nucleosome unstable; the H3mm7-
specific A57 residue is unable to form a hydrogen bond with the
cognate H4 molecule. H3mm7 may enhance the levels of
activated gene expression during differentiation by forming a
relaxed chromatin structure.
Results
H3mm7 is expressed in skeletal muscle tissues. We previously
reported that the histone variant H3mm7 is expressed in mouse
skeletal muscle tissues and its forced expression positively
enhances skeletal muscle differentiation in C2C12 cells14. We first
attempted to identify which cells in skeletal muscle tissues express
histone H3 variants. Mature skeletal muscle tissue is composed of
myofibers (MFs) and a small number of satellite cells (SCs), blood
vessels, and nerve tissues. Hence, global gene expression analysis
using CEL-Seq217 was performed at different stages of myogen-
esis. We prepared SCs by muscle injury induced by cardiotoxin
(CTX) injection into the gastrocnemius muscle in Pax7-CreERT2;
Rosa26-YFP mice, and then Pax7 (YFP)-expressing cells were
isolated as SCs (quiescent SCs from uninjured muscle and
activated SCs from injured muscle). MFs were isolated from the
extensor digitorum longus (EDL) muscle (see Methods for
details). We found that H3mm7 was preferentially expressed
in SCs (activated: Pax7+, Myod1+ cells and quiescent: Pax7+,
Calcr+ cells)18 compared with MFs (Fig. 1a and Supplementary
Fig. 1 for the correlation coefficient matrix of each sample). We
additionally confirmed the SC-specific expression of H3mm7
using variant-specific reverse transcriptase quantitative poly-
merase chain reaction (RT-qPCR) Supplementary Fig. 2a), as
used for H3.3-coding genes (H3f3a, H3f3b) (Supplementary
Fig. 2b). H3mm7 showed decreased expression in MFs
(p= 0.044); therefore, we considered H3mm7 to function in
earlier stages of skeletal muscle regeneration.
To evaluate the physiological function of H3mm7 in SCs
during muscle regeneration, we generated a H3mm7 KO mouse
line by introducing Cas9 protein and clustered regularly
interspaced short palindromic repeat (CRISPR)-derived RNA
(crRNA)/trans-activating crRNA (tracrRNA) into in vitro
fertilized zygotes by electroporation19 (Supplementary Fig. 3).
As expected, because both male and female H3mm7−/− mice
were viable and indistinguishable from control mice, H3mm7 was
not necessary during development. Immunostaining for devel-
opmental myosin heavy chain (dMHC) in the tibialis anterior
(TA) muscle from H3mm7−/− mice was performed at 14 days
after CTX injection (Fig. 1b). dMHC is transiently expressed in
regenerating fibers in the early phase but is downregulated in the
late phase of muscle regeneration20,21. Some dMHC-positive
immature regenerating fibers and a substantial number of thin
fibers were observed in H3mm7−/− TA muscle (Fig. 1b, c),
indicating that muscle regeneration was delayed in H3mm7−/−
mice.
We assessed whether the delay in muscle regeneration in
H3mm7 KO mice was caused by a decrease in the number of SCs.
Immunohistochemistry on day 5 after the induction of muscle
injury by CTX showed no notable change in the proportions of
Pax7(+)MyoD(−), Pax7(+)MyoD(+), and Pax7(−)MyoD(+)
cells around the regenerated muscle (Supplementary Fig. 4). We
next assessed changes in the gene expression profile upon KO by
RNA-seq (CEL-Seq2) using tissue sections. We fitted the gene
expression profile data under injured and uninjured conditions at
days 5 and 14 into a statistical model using the DESeq2 software
(Supplementary Table 1). We found that the injury-induced
changes to expression levels of SC-related genes were analogous
between H3mm7+/+ and H3mm7−/− mice. Of these SC-related
genes with high fold changes in Injured/Uninjured, Pax7
demonstrated a log2 fold change= 3.19 and its expression level
was 9-fold higher in the Injured condition on days 5 and 14.
Ncam1 similarly showed an 18-fold higher expression level in the
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Fig. 1 H3mm7 is required for normal skeletal muscle regeneration and differentiation. a The H3mm7 gene is expressed in satellite cells. The colors of the
tiles indicate the average expression level (n= 3) of H3 variants, satellite cell marker genes, and differentiation markers45 as the column-wise relative
expression levels (Z-score). b Some of the fibers showed incomplete muscle regeneration in H3mm7−/− mice. Immunostaining of a regeneration marker
(dMHC; red) and laminin (green) in TA muscle at 14 days after CTX injection. c CSA measurements of H3mm7−/− TA muscle fibers showed thinner fiber
formation during muscle regeneration. The approximated fiber diameters of H3mm7+/+ and H3mm7−/− mice are shown as box plots (n= 177, 175, 231,
161, 179, 154, 156, 132, 153, 251, 138, 192, 141, 339 cells for individuals, respectively). The signs at the bottom indicate the observed number of dMHC-
positive fibers (−: none, +: at least one, ++: >4). The medians, 25/75th percentiles, and 1.5 IQR (inter-quartile range) are employed to draw the box plots.
d H3mm7−/− cells showed SK muscle differentiation deficiency in C2C12 cells and an H3mm7-rescued clone recovered SK muscle differentiation.
Immunostaining of markers of fiber formation (MHC; red), rescued histone variants (GFP; green), and the nucleus (Hoechst; blue) in H3mm7−/− and
H3mm7+/+ C2C12 cells are shown. e The loss of skeletal muscle marker gene expression levels was partially rescued by the H3mm7 expression. The
expression levels relative to H3mm7+/+ at 48 h after differentiation stimuli were measured by RT-qPCR (n= 3). The error bars indicate ±1 SD. Two-sided
Welch’s t-test was performed and the p-values are Ckm: 0.001, 0.042, 0.003, Des: 0.002, 0.064, 0.032 and Eef1a1: 0.159, 0.126, 0.031 (H3mm7+/+ vs.
H3mm7−/−, H3mm7−/− vs. +H3mm7, H3mm7−/− vs. +H3.3 respectively). The scale bars in the immunostaining images are 100 µm
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Injured condition (log2 fold change= 4.19) and the interaction
term for Injured and Day 14 was −4.16 (one eighteenth), i.e., the
expression level returned to the level in uninjured muscle on day
14. We further observed that downregulated genes in H3mm7−/−
mice included mature muscle fiber-related genes, such as
Tnnc222,23. These results suggest that the loss of H3mm7 might
affect the differentiation process, while leaving the population of
SCs unchanged. We further evaluated the function of H3mm7 in
isogenic C2C12 cells, which express H3mm7 prior to differentia-
tion stimuli and are used as a differentiation model of
myogenesis24. Two independent clones of H3mm7 homozygous
KO (H3mm7−/−) C2C12 cells were constructed using the
CRISPR/Cas9-system (see Supplementary Fig. 5a, b for the
deletion strategy of H3mm7 in tetraploid C2C12 cells). Immu-
nostaining of the skeletal muscle marker MHC showed impaired
differentiation in H3mm7−/− cells (Fig. 1d). Furthermore, the
ectopic expression of H3mm7-GFP, but not H3.3-GFP, rescued
the expression level of MHC in H3mm7−/− cells (Fig. 1d,
lower panel). The fusion index for the time course of
differentiation showed that the formation of multinucleated
MFs in H3mm7-rescued cells was comparable to that in wild-type
(WT) (H3mm7+/+) cells, while H3.3-GFP decreased the fusion
index in H3mm7−/− cells (Supplementary Fig. 6). We also
evaluated the total amount of histone H3 in C2C12 cells using
an antibody that recognizes the C-terminus of histone H3 (anti-
H3-C; see Methods for details) and found no significant
difference in the amounts present (Supplementary Fig. 7a), while
the soluble H3-C level was decreased only in H3mm7−/− rescued
by H3mm7-GFP cells (Supplementary Fig. 7b). The expression of
exogenous green fluorescent protein (GFP)-fused histones did not
affect the endogenous H3 histones. Therefore, the impaired
differentiation in H3mm7−/− cells was not caused by insufficient
amounts of histone H3.
We also confirmed the result in terms of mRNA levels using
the representative skeletal muscle markers, Ckm and Des, and the
housekeeping gene, Eef1a1, as a control (Fig. 1e). The mRNA
level of Ckm, which is highly expressed in differentiation, was
lower in H3mm7−/− cells than in H3mm7+/+ cells at 48 h after
the differentiation stimulus (p= 0.001; lower than H3mm7+/+)
and was rescued by H3mm7 expression (p= 0.042; higher than
H3mm7−/−). H3.3 did not rescue the expression levels of Ckm at
48 h but rather caused a decrease in expression levels of some
myogenic genes (p= 0.003; lower than H3mm7−/−). Other
skeletal muscle-related genes highly expressed after differentia-
tion were also rescued by H3mm7 (Supplementary Fig. 8).
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Fig. 2 H3mm7−/− causes the rate change of gene expression during differentiation. a For all DEGs, the rate change of gene expression was observed
throughout the differentiation time course. The illustrations explain the result of the statistical test against RNA-seq data. b The four types of rate changing
patterns during differentiation are explained by the combination of the patterns: Up/Down in time and Above/Below in H3mm7−/− cells. The points
indicate the cluster average of the relative (gene-wise Z-normalized) expression levels of two cell types (H3mm7+/+ and H3mm7−/−) with two replicates.
The error bars indicate ± 1 SD. The numbers of the genes in the clusters are indicated in parentheses. c LDA extracted two major gene expression patterns
during differentiation that correspond to A/B and U/D. The points indicate the genes of the clusters in LD space spanned by LD1 (middle) and LD2 (right)
components. d The singular values of the LDA (the ratio of between- and within-cluster standard deviations) indicate that the two most relevant
components to discriminate the clusters were LD1 (A/B) and LD2 (U/D)
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rescued by H3.3 (p= 0.032), which was not the case for H3mm7
(p= 0.064). The levels of the control (housekeeping) gene Eef1a1
were not significantly changed in H3mm7+/+, H3mm7−/−, or the
rescued clones of H3mm7, although an elevated level of Eef1a1
was observed upon H3.3-GFP expression. Taken together, while
not all genes that were downregulated by the loss of the H3mm7
gene were rescued by the ectopic expression of H3mm7-GFP, a
group of myogenesis-related genes were observed to be
significantly rescued (Fig. 1e and Supplementary Fig. 8), suggest-
ing that H3mm7 might have a function to regulate these genes.
These results suggest that the expression of H3mm7 might affect
upregulated genes in differentiation.
H3mm7−/− causes rate changes in gene expression levels. Next,
to identify genes where expression levels were altered by H3mm7
during differentiation, we performed time-course RNA-seq ana-
lysis with C2C12 cells. We collected C2C12 cells at different
growth states 24, 48, and 72 h after initiation of the differentiation
stimulus.
We attempted to detect differentially expressed genes (DEGs)
that had lost the kinetics of normal myogenesis during
differentiation. Loss of gene expression kinetics is commonly
detected in the gene KO or knockdown models as representatively
shown in Supplementary Figs. 9 and 10 for si-mH2A1.2 in C2C12
cells25 and for BMAL KO in hip cartilage samples26, respectively.
In the latter study, the authors utilize DESeq2’s likelihood ratio
test in a set-up analogous to ours (Time and Phenotype factors)
to demonstrate that a group of genes lose the periodical pattern of
expression. Following their method, we employed a statistical
model using DESeq2 (a graphical explanation is provided in
Supplementary Fig. 11): Gene expression levels at time t in KO
cells= (WT expression level at time t)+ (KO effect through
time)+ (extra effect at time t in KO cells). However, the
likelihood ratio test of the model revealed that no genes
demonstrated a loss at any time point. Therefore, the results
indicated that no genes showed a complete loss or abnormal
activation of expression induced by loss of H3mm7 during
differentiation. The secondary finding from the statistical test was
that, for all DEGs, the change caused by H3mm7 KO could be
sufficiently explained by the “KO effect through time” term
above; i.e., the effect of H3mm7 KO was viewed as a constant rate
change (offset in log-scale) through time (Fig. 2a, Supplementary
Fig. 11). Overall, 3505 genes were detected as DEGs in H3mm7
−/− cells. We therefore hypothesized that the loss of H3mm7
caused the expression rate change of differentiation-related genes
and thus the proportion of successfully differentiated cells
decreased despite the isogenicity of the H3mm7−/− C2C12 cells.
To characterize these 3505 genes, we performed Gene
Set Enrichment Analysis (GSEA) (see Table 1 and Supplementary
Table 2 for detailed lists of the GSEA analysis results) to
extract H3mm7-dependent gene sets. As expected, negative
enrichment was observed in skeletal muscle cell differentiation
(GO:0035914; normalized enrichment score (NES)=−2.40).
In addition, increased inhibition of the response to the growth
factor, which is considered a reaction during skeletal muscle
differentiation, was also observed (GO:0090288; NES= 2.20).
However, myogenesis-independent gene sets were also enriched
both in the downregulated genes, for example, ribosome
biogenesis (GO:0042255, NES=−2.67), and the upregulated
genes, such as cilium assembly (GO:0042384, NES= 2.45). These
results suggest that, while H3mm7 is not involved specifically in
the expression of genes related to myogenic differentiation, it may
be required to upregulate gene expression upon differentiation.
To determine the temporal expression patterns of the genes
responsible for the rate change phenomenon during differentia-
tion, we classified the 3505 genes into categories according to
gene expression patterns in time. The k-means clustering of the
time-course RNA-seq data resulted in four types of gene
expression patterns that could be explained by the combination
of the upregulation/downregulation (abbreviations: U, D) in the
course of differentiation and the above/below (A, B) levels of gene
expression in H3mm7−/− cells compared with H3mm7+/+ cells
(Fig. 2b). Flat patterns (no significant change in time; cluster SA
and SB) were also observed but were not considered the result of
H3mm7−/−, because DESeq2 only captured the genes that varied
between the replicates of H3mm7+/+ cells (Supplementary
Fig. 12). These data indicated that loss of the H3mm7 gene
caused the rate change in expression of upregulated and
downregulated genes upon differentiation.
We further confirmed that the rate change had occurred with
upregulation/downregulation of gene expression after the loss of
H3mm7 by Fisher’s linear discriminant analysis (LDA). LDA was
used to estimate the superpositions of the expression patterns in
the clusters of Fig. 2b (Fig. 2c). The singular values (Fig. 2d)
representing the performance of the class separation showed the
Table 1 Top-enriched Gene ontology terms using GSEA for 3505 DEGs for H3mm7−/− vs. H3mm7+/+ C2C12 cells
Downregulated GO terms (top-15) NESa Upregulated GO terms (top-15) NESa
Ribosome biogenesis (GO:0042254) −2.666 Spleen development (GO:0048536) 2.562
Ribosome assembly (GO:0042255) −2.657 Cilium assembly (GO:0042384) 2.446
rRNA processing (GO:0006364) −2.645 Cilium morphogenesis (GO:0060271) 2.333
Translation (GO:0006412) −2.631 Cilium organization (GO:0044782) 2.304
Peptide biosynthetic process (GO:0043043) −2.59 Positive regulation of defense response to virus by host (GO:0002230) 2.289
rRNA metabolic process (GO:0016072) −2.581 Regulation of defense response to virus (GO:0050688) 2.259
Amide biosynthetic process (GO:0043604) −2.566 Cellular component assembly involved in morphogenesis (GO:0010927) 2.238
Ribosomal small subunit assembly (GO:0000028) −2.555 Negative regulation of transforming growth factor beta receptor signaling
pathway (GO:0030512)
2.233
Ribosomal small subunit biogenesis (GO:0042274) −2.553 Negative regulation of cellular response to transforming growth factor beta
stimulus (GO:1903845)
2.233
Ribosomal large subunit biogenesis (GO:0042273) −2.5 Positive regulation of calcium ion transport (GO:0051928) 2.206
ncRNA processing (GO:0034470) −2.486 Negative regulation of vasculature development (GO:1901343) 2.201
Organonitrogen compound biosynthetic process
(GO:1901566)
−2.441 Negative regulation of cellular response to growth factor stimulus
(GO:0090288)
2.201
Peptide metabolic process (GO:0006518) −2.412 Regulation of defense response to virus by host (GO:0050691) 2.194
Skeletal muscle cell differentiation (GO:0035914) −2.4 Cell projection morphogenesis (GO:0048858) 2.163
Regulation of myotube differentiation (GO:0010830) −2.372 Xenophagy (GO:0098792) 2.153
a NES normalized enrichment score
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03845-1 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1400 | DOI: 10.1038/s41467-018-03845-1 |www.nature.com/naturecommunications 5
two major components LD1 (first component of LDA; corre-
sponding to A and B) and LD2 (U, D) in contrast to the other
minor ones (LD3, 4, and 5). The singular values of LD1 and LD2
were 123.98 and 50.07 (84.3% and 13.8% of total between-class
variance), respectively. This suggested that the rate change (bias)
between H3mm7−/− and H3mm7+/+, and subsequently the
upregulation/downregulation in differentiation, were indeed the
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Fig. 3 The incorporation of H3mm7 enhances activated gene expression by increasing chromatin accessibility. a Trans-differentiation model by MyoD
infection using H3mm7/H3.3-GFP-expressing NIH3T3 cells. This model was utilized to confirm each dependency for exerting the function of H3mm7 on the
inherent cell lineage (skeletal muscle potential), transcription factor (MyoD), and differentiation stimuli (serum starvation). b The six types of gene
expression patterns in time-series RNA-seq data of NIH3T3 cells. The plot was created as in Fig. 2b. The error bars indicate ±1 SD of the genes (n: the
number of genes in the clusters) c Marked enhancement of gene expression occurred in activated genes during differentiation (cluster UA). The scatter plot
of log2-transformed fold change of gene expression (H3mm7+ vs. WT cells, through time) and chromatin accessibility changes (H3mm7+ vs. H3.3+ cells,
through time) are shown. The colors correspond to the clusters in b. The sizes of the points are proportional to −log10 (adjusted p-values of chromatin
accessibility change). Enhanced: upregulated genes in control NIH3T3 cells over time with higher expression levels and higher accessibility in H3mm7+ cells
compared with H3.3+ cells. Enhanced (negative): downregulated genes in control NIH3T3 cells over time with lower expression levels and lower
accessibility in H3mm7+ cells compared with H3.3+ cells. d The expression levels of genes that showed marked enhancement. The expression levels are
calculated as transcripts per million (TPM). e IGV snapshot of ATAC-seq shows increased chromatin accessibility at an H3mm7 incorporated promoter
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H3mm7 functions independently of muscle differentiation.
We found that knocking out the H3mm7 gene led to a rate
change in gene expression levels. However, it remains to be
determined whether H3mm7 functions independently upon
incorporation or only in concert with other factors. We con-
firmed that NIH3T3 fibroblast cells naturally lack the H3mm7
gene locus by analysis of amplicon sequences (Supplementary
Fig. 13). Hence, we performed time-course RNA-seq in
NIH3T3 cells with GFP-fused H3mm7 and with H3.3 as
control. In this experiment, if the rate change takes place after
differentiation induction by MyoD infection, it is transcription-
factor-dependent. However, if it occurs only upon over-
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As a result of k-means clustering of time-series RNA-seq data,
we obtained six clusters (U, D, S) × (A, B) for NIH3T3 cells
(Fig. 3b). The rate change in gene expression levels was observed
at all time points before infection (UI; uninfected) to 48 h after
differentiation induction. This indicates that the function of
H3mm7 is independent of MyoD infection and of differentiation
stimuli. Moreover, we determined that the expression of H3mm7
led to a greater rate change in expression levels compared with
that caused by H3.3 (Supplementary Fig. 14a). We also performed
an analysis analogous to that in Supplementary Fig. 14a against
control (Supplementary Fig. 14b). The results showed that
both H3mm7 and H3.3 cases demonstrated significant mean
differences against WT in all the clusters, which suggests that the
ectopic expression of H3.3 and H3mm7 have analogous effects on
the gene expression profile. However, the difference was not
significant at 24 h in the clusters UA and DA in the case of H3.3,
and H3mm7 induced greater rate changes in comparison with
H3.3; these facts might lead to the H3mm7-specific gene
expression profile.
GSEA analysis also showed a consistency of the C2C12 data
(Supplementary Table 3): that a rate change phenomenon was
observed in genes other than those related to skeletal muscle
differentiation (GO:1901861, Regulation of muscle tissue devel-
opment, NES= 2.07). We confirmed RNA-seq data by qPCR for
the representative differentiation marker genes belonging to
cluster UA (Supplementary Fig. 15). While the plot in Fig. 3b
showed notable rate changes in differentiation induced by
H3mm7, the genes in Supplementary Fig. 15 included those for
which the enhancement effect was greater in H3mm7 (Des and
Tnnt2), those in which H3.3 and H3mm7 have comparable
enhancement effects (Acta1, Ckm and Tnni2), and a group of
genes including Myh3 for which the ectopic expression of H3.3
resulted in lower expression levels compared with WT. The
results in Fig. 1d and Supplementary Fig. 6 show that H3.3 only
partially compensated the function of H3mm7; however, the
results of RNA-seq analysis in NIH3T3 cells also indicate that
H3mm7 has a greater impact on gene expression than H3.3.
H3mm7 enhances gene expression via accessible chromatin.
We investigated whether the H3mm7-specific function occurs
only after selective recruitment to specific regions induced by
recruitment factors, such as chaperones specific to H3mm7. First,
we evaluated whether there are unique H3mm7 incorporation
sites in NIH3T3 cells ectopically expressing GFP-tagged histone
H3 variants. Then we evaluated histone modifications (H3K4me3
and H3K27me3) at the sites of GFP-tagged histone incorporation
as well as chromatin accessibility by assay for transposase-
accessible chromatin using sequencing (ATAC-seq). Both
GFP-histones H3.3 and H3mm7 were preferentially incorporated
in promoter regions (Supplementary Fig. 16 for GFP peak
annotations) and did not show a substantial difference in the
incorporated sites on the genome. H3K4me3 and H3K27me3
were not affected either in signal levels or their distribution
pattern on the genome by the ectopic expression of GFP-histones
H3.3 and H3mm7 compared with control NIH3T3 cells (Sup-
plementary Figs. 17 and 18). Therefore, this indicates that the
regulation of expression rate by H3mm7 incorporation did not
originate from the specific change of histone modification or
incorporation sites on the genome. Despite the fact that H3.3 and
H3mm7 are nearly identical in their sequences, localization, and
histone modification preferences, the rate change effect of
H3mm7 made a notable difference in the gene expression profile
after differentiation.
We, therefore, focused on genes whose chromatin structures
were altered as a result of the forced expression of H3mm7. First,
we identified the group of genes with increased accessibility to
H3mm7 vs. control NIH3T3 cells by evaluating the ATAC-seq
signal levels in the promoter regions (Fig. 3c). H3mm7-induced
DEG groups, classified in Fig. 3b, were used to determine groups
that caused a change in chromatin accessibility. As in the case of
the gene expression profiles considered above, the mean
accessibility levels were already high at the UI stage when the
variant is incorporated, and the high accessibility levels were
maintained after differentiation (Supplementary Fig. 19). Then
we evaluated the relationship between the fold change in
accessibility (H3mm7+ cells/H3.3+ cells) and the fold change
in gene expression (H3mm7+ cells/WT) by scatter plot (Fig. 3c).
The enhancement effect of H3mm7 on gene expression was
greater than that of H3.3 (Fig. 3b and Supplementary Fig. 14);
therefore, we compared the numbers of genes belonging to cluster
UA in quadrants I and IV (i.e., greater enhancement effect both
in chromatin accessibility and gene expression in H3mm7+ cells
vs. greater enhancement effect in H3.3+ cells). We found the
result to be I: 39 vs. IV: 9, and hence we confirmed that there were
more genes with enhancement levels greater by >2 fold changes in
chromatin accessibility and gene expression induced by the
ectopic expression of H3mm7 (Supplementary Fig. 20). There-
fore, we concluded that genes belonging to cluster UA were
enhanced more in both accessibility and expression by H3mm7
than by H3.3. We observed increased expression levels for
individual genes after induction of H3mm7 (Fig. 3d). Figure 3e
shows increased accessibility of the representative Tmeff2 gene
promoter upon H3mm7 induction (2.66 fold change compared
with H3.3+ cells; adjusted p= 4.07 × 10–12) while the Eef1a1
promoter showed no difference between H3.3- and H3mm7-
incorporated promoters (adjusted p= 0.36). We additionally
performed ATAC-seq analysis using WT and H3mm7-KO
C2C12 cells (Supplementary Fig. 21). The data demonstrated
that loss of H3mm7 caused a decrease in chromatin accessibility
(chromatin accessibility up: 25 genes, down: 137 genes), while
the expression levels of the affected genes were decreased
only after differentiation stimuli (Supplementary Fig. 22). These
results suggest that H3mm7 is expressed prior to differentiation
and supports the differentiation process. Together, these
results suggest that the change of chromatin accessibility at
Fig. 4 Ala57 allows the mobility of the H3mm7 nucleosome. a T32I and S57A are only the differences between H3.3 and H3mm7. N-terminals of the amino
acid sequence of H3.3 and H3mm7 are shown in the illustration of the secondary structure. b High-resolution crystal structure of an H3mm7-containing
nucleosome shows the loss of interaction between H3.3S57 and H4R40 in the H3mm7 nucleosome. An overview of the crystal structure of the H3mm7-
containing nucleosome (left) and the comparative view around S57 in H3.3 and A57 in H3mm7 (right). c H3mm7 nucleosomes were dissociated at a
concentration of 600mM NaCl. The salt-titration assay of H3mm7, H3.3, and the mutant (H3.3S57A and T32I) containing nucleosomes is shown. The
positions of the bands that correspond with the intact nucleosome core particle and naked DNA are indicated on the right. d H3.3S57A and H3mm7
dissociated from the H2A:H2B dimer faster than the other H3 variant-containing nucleosomes. Thermal stability assay of H3mm7, H3.3, and the point
mutants H3.3T32I and H3.3S57A. The lines show the fluorescent intensity that indicates nucleosome dissociation at each temperature. The error bars are
± 1 SD (n= 4). e H3mm7 and H3.3S57A showed a fast histone turnover. FRAP analysis of nucleosomes containing GFP-fused H3mm7, H3.3, and the point
mutants. Representative confocal images of FRAP analysis in each H3 variant nucleosome is shown on the left. Plot of average GFP fluorescent recovery
rate at each time point after photobleaching is shown on the right. The error bars are ± 1 SD. The number of replicates is indicated in parentheses
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H3mm7-incorporated genes enhances the upregulation of the
expression of myogenic-differentiation-related genes notably in
cluster UA to a greater degree compared with H3.3+ cells.
The S57A substitution causes unstable nucleosomes with
H3mm7. H3.3 and H3mm7 differ in their amino acid sequences
only at T32I and S57A (Fig. 4a); however, it is not clear how this
small difference in the amino acid composition of H3 results in a
marked difference in function of the nucleosome. We therefore
analyzed the crystal structure of the nucleosome containing
H3mm7 (Fig. 4b). The overall structure of the H3mm7 nucleo-
some is quite similar to that of the H3.3 nucleosome. However,
we found that the interaction between H4R40 and H3.3S57 in the
H3.3 nucleosome is absent in the H3mm7 nucleosome, because
the S57 residue of H3.3 is replaced by alanine in H3mm7. The
dissociation of nucleosomes was observed for both H3mm7 and
H3.3S57A under conditions of 600 mM NaCl, but this dissocia-
tion was not observed in nucleosomes with H3.3 and H3.3T32I.
This suggests that S57A incorporation results in unstable
nucleosomes (Fig. 4c). A thermal stability assay was then per-
formed to evaluate the stability of variant nucleosomes (Fig. 4d).
The first peak of the fluorescence intensity curve reflects
H2A–H2B dissociation, and the second peak reflects the
dissociation of H3–H427. We found that the H2A–H2B dimer
became dissociated at lower temperatures (60–70 °C) in nucleo-
somes containing H3mm7 and the H3.3S57A mutant compared
with those containing H3.3 and the H3.3T32I mutant. These
results indicate that H3mm7 nucleosome stability is less than that
of the H3.3 nucleosome and that the H3mm7-specific alanine
residue at position 57 is fully responsible for reduced stability of
the H3mm7 nucleosome.
To investigate the effect of unstable nucleosomes on the
stability of histone variant incorporation in vivo, we performed
fluorescence recovery after photobleaching (FRAP) (Fig. 4e).
After photobleaching, the fluorescence intensity of GFP-H3.3 and
GFP-H3.3T32I dropped to ~10% of the original intensity and
recovered to ~20% in 240 min. The intensity just after bleaching
was slightly higher for GFP-H3mm7 and GFP-H3.3S57A and
recovered up to ~50–60%, indicating that these proteins exchange
more rapidly than GFP-H3.3 and GFP-H3.3T32I. Therefore, we
concluded that H3mm7 is more mobile than H3.3 in cells,
probably because of unstable nucleosome formation due to the
A57 residue of H3mm7.
To further assess the enhancement of H3.3S57A on gene
expression, we performed RNA-seq for NIH3T3 cells ectopically
expressing H3.3S57A/T32I mutants. As expected, the S57A
mutant enhanced the expression levels of Myh3, Myog, and
Tnnt2 genes upon differentiation stimuli (representative marker
genes of skeletal muscle differentiation, Supplementary Fig. 23),
whereas the T32I mutant did not.
Discussion
Here we found that H3mm7 is substantially expressed in skeletal
muscle SCs. The loss of H3mm7 resulted in delayed skeletal
muscle regeneration upon CTX injury. These data suggest that,
although H3mm7 is the sub-variant of H3.3, its functions are
required for proper muscle regeneration via specific chromatin
formation.
The detection of these minor histone variants has been
impaired by their highly homologous coding sequences
(76%–98.5% compared with H3.3)14. Therefore, we previously
employed 3ʹ-seq28 to specifically detect the expression levels of
novel histone variants in large quantities of RNAs14. In the
current study, we used CEL-Seq2 to quantify the expression levels
of histone variants and confirmed the variant expression in
skeletal muscle stem cells and progenitor cells. Although we have
focused on H3mm7 expressed in skeletal muscle, these approa-
ches could be applicable to future studies to detect other histone
H3 variants in specific tissues. Several KO studies have produced
conflicting results. Jang et al. showed that double-KO mice
(H3f3a and H3f3b) resulted in lethality around embryonic stage
3.5 days post coitum6; however, in H3f3b KO and H3f3a-shRNA-
suppressed embryonic stem cells, dysfunction of differential
potential was observed29. It is possible that the function of H3.3
could be disrupted along with the other H3.3 sub-variants
because H3.3 sub-variants (H3mm6-H3mm18) share similar
shRNA target sequences8,9.
The absence of H3mm7 might have disrupted the expression of
genes, including those related to skeletal muscle, in the cell
population. This non-uniformity in gene expression might
manifest as the rate change of gene expression seen in the bulk
cell RNA-seq data. Future single-cell analysis might determine
whether this rate change phenomenon is mediated by single-cell-
level expression variations or from the aggregate of the changes in
gene expression levels in each cell. For instance, it has been
reported that nucleosome positioning in yeast promoters
is involved in the regulation of expression noise30. Thus the
regulation of nucleosome positioning by H3mm7 might result in
the rate change of gene expression. Furthermore, some
transcription-repressive chromatin regulatory factors regulate
the probability of inactivation of gene expression rather than
suppressing gene expression levels in the cell population. This
suggests that the presence of a variant in the nucleosome that
interacts with a chromatin regulatory factor causes variations in
the rate parameters (kon/koff) for the activation and inactivation
of genes31 in the local area of H3mm7 nucleosome sites. To
elucidate this, it is necessary to perform single-cell synthetic
biological analysis on chromatin containing the variant.
Histone variants might be another vital factor along with
transcription factors in determining unique expression profiles of
tissues. In our analysis using KO mice, H3mm7 deficiency did
not have a dramatic effect on animal development, although a
phenotype in adult muscle regeneration was observed. H3mm7 is
poorly conserved across species, even in mammals; however,
H3mm7 corresponds to H3F3AP3 in humans, which also has the
A57 residue. In the H3.3 nucleosome, the S57 residue forms a
hydrogen bond with the R40 residue of the cognate H4 molecule.
The crystal structure of the H3mm7 nucleosome revealed that the
A57 residue of H3mm7 does not affect the nucleosome structure,
but the residue is unable to form a hydrogen bond with H4
because of the absence of a hydrogen donor (Fig. 4b). Amino
acid conservation of such a key residue may be an important
hallmark for identification of functional histone variant homologs
across species. In-depth molecular evolutionary analysis of these
less-conserved histone variants might further our understanding
of histone variants as a driving force in evolution. Another
histone variant, H3mm11, showed an expression pattern closer to
that of H3f3a than to that of H3mm7 (Fig. 1a). GFP-H3mm11
was detected in abundance in TSS and its gene expression
profile was observed to change after differentiation14. Hence, the
structural changes in chromatin manifested through various
expression patterns of histone variants might contribute to the
transition of chromatin status at cell differentiation.
Because H3mm7 and H3.3 had similar patterns of incorpora-
tion and histone modification, the observed difference in their
functions might be sought in the difference in their amino-acid
residues. For instance, the phosphorylation of H3 T32 has been
reported for plant and animal cells32,33. Since peptides with H3
T32ph have a slightly increased number of interactions with
histone chaperones34, H3T32I might induce a change in the
status of such interactions. H3K56ac is a critical modification for
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nucleosome assembly in yeast35,36 and the S57 residue in H3.3
is replaced by alanine in H3mm7. Phosphorylation of serine
57 promotes a nucleosomal transaction when lysine 56 is
acetylated37. However, the binary switch model indicates a
‘methyl/phos switch’ between Lys56 and Ser5738. This supports
the idea that H3mm7 promotes the function of K56ac. Structural
and biochemical analyses demonstrated that H3mm7 nucleo-
somes are unstable without posttranscriptional modification. The
modification of S57A-substituted H3.3 will be studied in future.
Methods
Ethical statement. All animal procedures were conducted in accordance with the
Guidelines for the Care and Use of Laboratory Animals and were approved by the
Institutional Animal Care and Use Committee (IACUC) at Kyushu University,
Nagasaki University and Tokushima University.
Generation of H3mm7 KO mice. H3mm7 KO mice were generated with a genome
editing technique as described previously with several modifications19. Briefly,
in vitro fertilized zygotes (C57BL/6 × C57BL/6) were electroporated with 100 ng/µl
Cas9 protein, 100 ng/µl crRNAs, and 100 ng/µl tracrRNA. Two crRNAs targeting
upstream and downstream of H3mm7 gene were used. We designed the target
sequences of two crRNAs as follows: H3mm7 crRNA1 (5′-TATAGA-
TAAAGGAATAACTA-3′), H3mm7 crRNA2 (5′-ACATCACTTATC-
TATTGCTT-3′). Electroporated zygotes were transferred into the oviduct of
pseudopregnant female mice, and the mutant mice were born on E19. Cas9 pro-
tein, crRNAs, and tracrRNA were purchased from IDT.
CEL-Seq2 and data analysis. Pax7-CreERT2;Rosa26-YFP mice39,40 were treated
with tamoxifen to induce yellow fluorescent protein (YFP) in a Pax7-expressing SC
population. Tamoxifen dissolved in corn oil (5 µl/g of 20 mg/ml) was injected
intraperitoneally into mice daily for 3 days prior to the induction of muscle injury.
Muscle injury was induced by the intramuscular injection of 100 µl CTX (10 µM;
(Sigma-Aldrich, St. Louis, MO) into the gastrocnemius muscles of anaesthetized
mice using a 29-gauge 1/2 insulin syringe. Regenerating muscles were isolated
1 day after CTX injection. Mononuclear cells from uninjured or injured
gastrocnemius muscles (quiescent SCs and activated SCs) were prepared using
0.2% collagenase type II (Worthington Biochemical, NJ, USA) as previously
described41,42. The YFP-positive SC population was sorted using a fluorescence-
activated cell sorting (FACS) Aria II flow cytometer (BD Immunocytometry
Systems, CA, USA). Debris and dead cells were excluded by forward scatter, side
scatter, and PI gating. Data were collected using the FACS Diva software (BD
Biosciences, CA, USA). Individual MFs were isolated from the EDL muscle as
described previously42. Transcriptome analysis of quiescent SCs, activated SCs, and
MFs were performed as previously described17. The libraries were sequenced using
Illumina MiSeq and the reads were mapped to the mouse reference genome
(mm10) by the Bowtie 2 software (version 2.2.6)43. The 3ʹ-untranslated regions of
the histone variants were determined by visualizing the alignments using the
Integrative Genomics Viewer. Gene counting was performed using HTSeq44 and
the counts for a gene with the same UMI were counted as one (UMI counts).
The Z-scores for each SC marker gene45 were calculated with the UMI counts
normalized using the DESeq2 software46. In addition, Pearson correlation coeffi-
cients were calculated with the common logarithm of the UMI counts for those
genes with non-zero counts in at least one sample.
Muscle regeneration studies. Muscle regeneration studies were performed as
previously reported, except for the injection of CTX into the TA muscle47.
Immunohistochemistry in Fig. 1b was performed as described in ref. 48, except
that ice-cold acetone was used for fixation instead of paraformaldehyde. Primary
antibodies used were rat anti-laminin-2 alpha 4H8-2 (1:200) (L0663, Sigma-
Aldrich) and mouse anti-dMHC (RNMy2/9D2) (1:50) (Leica Biosystems,
Germany). Secondary antibodies were Alexa Flour 488-labeled goat anti-rat (1:800)
(Thermo Fisher Scientific, Yokohama, Japan) and CF 568-labeled goat anti-mouse
(1:800) (Biotium, Fremont, CA). Samples were viewed on a Keyence BZ-X700
microscope (Keyence, Osaka, Japan), following mounting with ProLong Diamond
Antifade Mountant with 4,6-diamidino-2-phenylindole (DAPI; Thermo Fisher
Scientific).
For the immunohistochemistry shown in Supplementary Fig. 4, at 5 days after
CTX injection, three cryosections of the TA muscle were prepared from each
mouse. Antibodies used were: rabbit anti-Pax7 (PA1-117, Thermo Fisher Scientific,
1:200), rat anti-MyoD49 (1:200), rat anti-laminin-2 alpha 4H8-2 (L0663, Sigma-
Aldrich, 1:200), and rabbit anti-laminin antibodies (L-9393, Sigma-Aldrich, 1:500).
Images were visualized using a fluorescence microscope (BZ-9000; Keyence, ×40
objective). For each section, 4–9 high-power fields were combined. For
quantification of Pax7- and MyoD-positive cells, threshold was determined using
cytoplasmic signals of non-specific background, DAPI-negative areas were
removed, and then areas with specific signals over threshold were counted.
Similarly, MFs were defined as areas surrounded by laminin staining, and then the
number was counted. Image processing and cell counting were performed using the
BZ-X analyzer software.
For cross-sectional area measurements: Frozen sections of mouse TA muscles
were stained with hematoxylin and eosin. Images were obtained with a BZ-X700
microscope at 20× objective magnification. MF cross-section areas (μm2) were
measured using the BZ-X analyzer (Keyence, Osaka, Japan).
Cells. C2C12 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 20% fetal bovine serum. Undifferentiated cells were harvested
at 60–70% confluence. Differentiated cells were transferred to DMEM containing
2% horse serum upon reaching confluence. NIH3T3 cells were infected with
retrovirus-expressing MyoD as described previously10. These cells were purchased
from the American Type Culture Collection (ATCC, VA, USA).
Generation of GFP-fused histone H3 variant cell lines. H3f3a and H3mm7
cDNAs were used for the expression of H3.3 and H3mm7 as previously reported14.
H3.3 S57A and H3.3 T32I cDNAs were generated by the site-directed mutagenesis
method for the H3f3a cDNA template. cDNAs were ligated into the Bidirectional
Tet Expression Vector pT2A-TRETIBI (modified Clontech Tet-On system), which
contains TolII transposon elements and an EGFP cDNA located upstream of the
cDNA sequence (GFP-H3: N-terminus)14. pT2A-TRETIBI/EGFP-H3 variant
transfection was performed using Lipofectamine 2000 (Life Technologies, Carlsbad,
CA). NIH3T3 cells at 50% confluence were transfected with an expression vector
(2 µg plasmid DNA per well in a 6-well plate), pCAGGS-TP encoding transposase
(provided by Dr. Kawakami), and pT2A-CAG-rtTA2S-M2 and incubated for 24 h.
To create cell lines with the stable expression of GFP-H3 variants, the transfected
cells were cultured for 14–21 days in the presence of 1 µg/ml doxycycline and
1 mg/ml G418. GFP-positive cells were selected by FACS.
Generation of H3mm7 KO C2C12 cell lines. H3mm7 genomic loci were disrupted
using the CRISPR/Cas9 system. Sequences of the form N20-NGG in the assigned
region were first extracted using the Bowtie software (version 0.12.8). Then unique
sequences, such that variations with less than three mismatches do not exist outside
the considered region, were selected as candidates for gRNAs50. A gRNA sequence
targeting H3mm7 (Chromosome 13: 117,358,212-117,358,622; GRCm38) was
cloned into pSpCas9 (BB)-2A-GFP (PX458, Addgene). The plasmid was trans-
fected into C2C12 sells using Lipofectamine 2000 Transfection Reagent (Thermo
Scientific), in accordance with the manufacturer’s instructions. To delete the
H3mm7 gene locus completely, we performed transfection in three stages with
three pairs of gRNAs. At 24 h after the transfection of the first pair, GFP-positive
cells were isolated by cell sorting. The second pair of gRNAs was then transfected
in these cells. Finally, at 24 h after the transfection of the third pair, GFP-positive
cells were sorted into 96-well plates to establish single-cell clones that were sub-
jected to genotyping by PCR. H3mm7−/− (homo deletion of H3mm7 loci) clones
were obtained by detection using Sanger sequencing and amplicon sequencing. The
gRNA and primers used in this study are listed in Supplementary Table 4. For
rescue experiments, the pT2A-TRETIBI/H3mm7-EGFP or H3.3-EGFP cDNA
plasmids (C-terminus) were stably transfected into H3mm7−/− C2C12 cell lines
(it was confirmed that both C- and N-terminus tags of histone H3 produced
comparable effects in C2C1210,14). GFP-positive cells were selected as rescue
clones by FACS.
FRAP. FRAP was performed as described51 using a confocal microscope (FV-1000;
Olympus) with a 60× PlanApoN Oil SC NA= 1.4 lens. A confocal image of a
field containing 2–5 nuclei was collected (800 × 800 pixels, zoom 1.2, scan speed
2 µs/pixel, pinhole 800 µm, 4 line averaging, BA505 emission filter, and 0.1%
transmission of 488-nm Ar laser), one half of each nucleus was bleached using
100% transmission of a 488-nm laser, and images were collected using the original
setting at 5 min intervals.
Immunocytochemistry. Cells were plated in 24-well plates (ibidi USA Inc., WI,
USA), washed twice with phosphate-buffered saline (PBS), fixed with 1% paraf-
ormaldehyde in PBS for 10 min, permeabilized with 0.5% Triton X-100 in PBS, and
washed twice with PBS. A 15min incubation with Blocking One (Nacalai Tesque
Inc.) was followed by a 2 h incubation with mouse anti-MHC (Calbiochem, 1:100;
Fig. 1d) diluted with 10% Blocking One in PBS at room temperature. The wells
were then washed three times with PBS and incubated for 30 min at room
temperature with CF568-labeled goat anti-mouse (1:1000; Biotium Inc.) and
bisbenzimide H33342 fluorochrome trihydrochloride (Hoechst) (1:5000; Nacalai
Tesque Inc.) diluted with 10% Blocking One in PBS. Wells were washed three times
in PBS and mounted in ibidi mounting medium (ibidi USA, Inc.). Images were
visualized using a fluorescence microscope (BZ-9000; Keyence). The fusion index
was evaluated using the ImageJ software.
Immunoblotting. Cells were washed twice with PBS, centrifuged, and then
resuspended in 2× sodium dodecyl sulfate (SDS) sample buffer. The samples
were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred
to a polyvinylidene fluoride membrane with a Trans-Blot Turbo Transfer System
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(Bio-Rad Laboratories, Hercules, CA). The membrane was blocked for 1 h in 5%
(w/v) skim milk in Tris-buffered saline containing 0.05% (v/v) Tween 20 (TBST),
then incubated with primary antibodies in Hikari Solution A (Nacalai Tesque Inc.)
followed by incubation with horseradish peroxidase-labeled secondary antibodies
and detection using Chemi-Lumi One Ultra (Nacalai Tesque Inc.). The primary
antibodies used in Supplementary Fig. 7 included rabbit anti-Hsp90 (H-114,
Santa Cruz Biotechnology, 1:1000) and anti-H3-C (1G1, hybridoma supernatant,
1:1000)52. Secondary antibodies were horseradish peroxidase-conjugated anti-
rabbit and anti-rat IgG antibodies (NA934 and NA935, GE Healthcare, 1:5000).
Cells were fractionated into soluble and chromatin fractions51 and the total amount
of H3 in these fractions was determined. Cells were washed twice with PBS and
then lysed in ice-cold physiological buffer (100 mM CH3COOK, 30 mM KCl,
10 mM Na2HPO4, 1 mM DTT, 1 mM MgCl2, 1 mM ATP, 0.1% Triton X-100, and
protease inhibitor cocktail). Lysates were incubated for 10 min on ice and then
centrifuged at 1000 × g for 5 min. The supernatants including soluble fractions were
pelleted to be concentrated by trichloroacetic acid precipitation. The pellets and
chromatin were resuspended in 2× SDS sample buffer. Lamin B1 (12987-1-AP,
Proteintech, 1:1000) antibody was used as nuclear loading control. Uncropped
images are given in Supplementary Fig. 24.
Quantitative RT-PCR. Total RNA was isolated and reversed-transcribed with
PrimeScript Reverse Transcriptase (Takara Bio Inc.) and an oligo dT primer
according to the manufacturer’s instructions. qPCR was performed using
Thunderbird qPCR Mix (Toyobo Co., Ltd.). Primers are listed in Supplementary
Table 5. qPCR data were normalized to Gapdh expression levels and presented as
the mean ± standard deviation of three independent experiments.
Variant-specific qRT-PCR. Allele-specific real-time PCR was employed to detect
the expression of H3mm753. SCs were expanded from Pax7-positive SCs, most of
which were activated54. Real-time PCR amplification and detection were performed
in a Pico Real-Time PCR machine under standard thermocycling conditions: 30 s
at 95 °C, 45 cycles of 5 s at 95 °C, 30 s at 55 °C, and 30 s at 72 °C. The expression
level of H3mm7 was evaluated as the ratio relative to the level of H3f3a. The
primers used are listed in Supplementary Table 6.
Chromatin immunoprecipitation. ChIP assays were performed as described pre-
viously with some modifications9. Briefly, cultured cells were cross-linked in 0.5%
formaldehyde and suspended in ChIP buffer (5 mM PIPES, 200 mM KCl, 1 mM
CaCl2, 1.5 mM MgCl2, 5% sucrose, 0.5% NP-40, and protease inhibitor cocktail;
Nacalai Tesque Inc.). The samples were incubated for 15 min on ice, sonicated for
5 s three times, and digested with micrococcal nuclease (1 µl; New England Biolabs,
Ipswich, MA) and Ribonuclease A (1 µl; Nacalai Tesque Inc., Kyoto, Japan) at 37 °C
for 40 min. The digested samples were centrifuged at 15,000 × g for 10 min.
Supernatant containing 4–8 µg DNA was incubated with a rat monoclonal anti-
body against GFP (Bio Academia Co. Ltd., 1A5, 2 µg) and mouse monoclonal
antibodies against H3K4me3 (2 µg)55 or H3K27me3 (2 µg)56 pre-bound to mag-
netic beads at 4 °C overnight with rotation. The immune complexes were eluted
from the beads using 1% SDS in TE, followed by washing with ChIP buffer and TE
buffer (both twice). Cross-links were reversed, and DNA was purified by a Qia-
quick PCR purification Kit (Qiagen, Valencia, CA).
ChIP-seq. ChIP libraries of GFP, H3K27me3, and H3K4me3 were prepared using
the NEBNext Ultra DNA Library Prep Kit for Illumina (New England Biolabs)
with biological duplicates. The libraries were sequenced on Illumina HiSeq
1500 sequencers. The data were aligned to mouse genome (GRCm38) using
HISAT2 (version 2.0.4), and the uniquely mapped reads were retained for the
following analysis. For the visualization of ChIP-seq signals on the Integrative
Genomics Viewer, read counts of 100 bp bins in the genome were normalized as
reads per million (RPM; multiplying a scaling factor of 106/total number of reads).
The RPM counts of each bin were then smoothed by averaging each center ±5
adjacent bins (smoothing with 1000 bp window).
RNA-seq. Total RNA at the growth and differentiated (i.e., post-differentiation)
states for C2C12 cells and NIH3T3 cells were obtained as described above. Library
preparation and sequence analysis were performed according to the manufacturer’s
protocol (NEBNext Ultra Directional RNA Library Prep Kit for Illumina). In the
analysis of H3mm7−/− C2C12 cells using DESeq2 software, the interaction effect
was tested using a likelihood ratio test with the full model: Time (Growth, 24, 48
and 72 h)+ Condition (H3mm7−/− and H3mm7+/+ cells)+ Time × Condition
(interaction term), vs. the reduced model: the full model without the interaction. In
response to the result of the test (no genes had interactions), the DEGs from the
reduced model were employed in the subsequent analysis. The contrasts of the
Condition term (log2FC of H3mm7−/− vs. H3mm7+/+) of 3505 genes met the
criteria: Benjamini and Hochberg corrected Wald p < 0.1 and baseMean >100
(the average expression level for all conditions). The DEGs in the RNA-seq data of
NIH3T3 cells, which have four time points (UI, 0, 24, and 48 h) and three
conditions (H3.3+, H3mm7+, and WT), were extracted by fitting the model
without interaction as performed in C2C12 cells. The preranked GSEA57 with the
log2FC values of DEGs was performed using the fgsea package58 and visualized
using the DOSE package59 in R. The regularized log-transformed (rlog function in
DESeq2) read counts of genes were utilized as the gene expression level in the
following analysis. K-means clustering, kmeans function in R with the options:
k= 6, algorithm= “Lloyd”, nstart= 200, iter.max= 1000, was performed against
the regularized log counts of the extracted DEGs. Linear discriminant analysis was
done using the lda function in the MASS package of R with the given class label of
the clusters.
ATAC-seq. For ATAC sequencing, 50,000 sorted cells were centrifuged at 800 × g
for 5 min, followed by a wash using 500 µl of cold PBS and centrifugation at 800 × g
for 5 min. Cells were lysed using cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM
NaCl, 3 mM MgCl2, and 0.1% IGEPAL CA-630). Immediately after lysis, nuclei
were spun at 500 × g for 10 min using a refrigerated centrifuge. Next, the pellet was
resuspended in the transposase reaction mix (10 µl 2× TAPS+DMF buffer, 1.5 µl
transposase (in house)60 and 8.5 µl nuclease-free water). The transposition reaction
was carried out for 30 min at 37 °C and immediately placed on ice. Directly
afterwards, the sample was purified using a Qiagen MinElute Kit. Following
purification, the library fragments were amplified using custom Nextera PCR
primers 1 and 2 for a total of 15 cycles. Following PCR amplification, the libraries
were purified using a Qiagen MinElute Kit. Paired-end sequencing was performed
with 100 cycles on an Illumina HiSeq 1500 platform. The differentially accessible
genes were extracted using DESeq2. We employed an index of gene accessibility
as the ATAC-seq read counts in a promoter region (2 kb upstream from TSS). The
fitted model is: Time (UI, 0, 24, and 48 h)+ Clone (H3mm7+, H3.3+, and
WT cells), with the option: fitType= “local”.
Purification of nucleosomes with mouse histone variants. All recombinant
histones (H2A, H2B, H4, H3.3, H3mm7, and H3.3 mutants) were bacterially
produced and purified by Ni-NTA agarose chromatography followed by MonoS
chromatography (GE Healthcare) as previously described61,62. To form histone
complexes (H2A–H2B dimer and H3–H4 tetramer), H2A and H2B or H3 and H4
were mixed at an equimolecular ratio in 20 mM Tris-HCl (pH 8.0) buffer, con-
taining 7M guanidine hydrochloride and 20 mM 2-mercaptoethanol. After the
samples were dialyzed against a refolding buffer (10 mM Tris-HCl (pH 7.5), 1 mM
EDTA, 2 M NaCl, and 2 mM 2-mercaptoethanol), histone complexes were purified
by chromatography on Superdex 200 gel filtration column (GE Healthcare), as
previously described63. The nucleosomes were reconstituted with the H2A–H2B
dimer, the H3–H4 tetramer, and the 146 base-pair DNA derived from human
alpha-satellite DNA by the salt-dialysis method63. The reconstituted nucleosomes
were purified using Prep Cell apparatus (Bio-Rad)64.
Crystal structures for the mouse H3.3 and H3mm7 nucleosomes. Purified
nucleosomes containing H3.3 or H3mm7 were crystallized by the hanging-drop
vapor diffusion method62. For X-ray diffraction experiments, nucleosome crystals
were soaked in a reservoir buffer (20 mM potassium cacodylate (pH 6.0),
45–60 mM MnCl2, 35–45 mM KCl) supplemented with 30% 2-methyl-2,4-penta-
nediol and 2–3% trehalose. The crystals were flash-cooled in liquid nitrogen.
Diffraction data of the nucleosomes were collected at BL41XU beamline station in
SPring-8 (Harima, Japan) and at BL1A, BL5A, and BL17A beamline stations in
Photon Factory (Tsukuba, Japan). The diffraction data were analyzed by HKL2000
and CCP465,66. The structures were solved by the molecular replacement method
with the Phaser program using the structure of the human H3.3 nucleosome (PDB
ID: 3AV2) as the search model64,67. The structural refinement was performed by
the PHENIX and COOT software68,69. The H3.3 and H3mm7 nucleosome struc-
tures were determined at 2.87 Å and 3.45 Å resolutions, respectively. The structural
data have been deposited in the RCSB Protein Data Bank [PDB ID: 5XM0 (for
H3.3 nucleosome) and 5XM1 (for H3mm7 nucleosome)]. All structure figures were
generated with the PyMOL software (http://www.pymol.org). The detailed list of
the data collection and refinement statistics are shown in Supplementary Table 7.
Thermal stability assay. For the thermal stability assay of the nucleosomes,
purified nucleosomes were mixed with 5× SYPRO Orange (Sigma-Aldrich) in
10 mM Tris-HCl buffer (pH 7.5) containing 100 mM NaCl and 1 mM dithio-
threitol, and the experiments were performed as described previously27. The
intensities of fluorescence signals emitted from SYPRO Orange bound to denatured
histones were normalized relative to the signal at 95 °C.
Salt-resistance assay. For salt-resistance assays of the nucleosomes62, purified
nucleosomes were incubated at 55 °C in 10 mM Tris-HCl buffer (pH 7.5), con-
taining 1 mM dithiothreitol and NaCl (0, 500, 600, or 700 mM), for 1 h. The
samples were then analyzed by non-denaturing PAGE stained by ethidium
bromide.
Code availability. The codes used for our deep-sequencing data analysis are
available at https://github.com/kazumits/DataAnalysisForH3mm7.
Data availability. The next-generation sequencing data are deposited in GEO
[GEO: GSE104389] and in the DNA Data Bank of Japan [DDBJ: DRA005975,
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DRA006453], and the structures of the H3.3 and H3mm7 nucleosomes are
archived at Protein Data Bank [PDB: 5XM0, 5XM1].
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